Burns McClellan’s PR team has background in key sectors within the life sciences, including: breakthrough therapeutics, drug delivery, diagnostics and devices; diverse disease areas (such as oncology, cardiovascular disease, orphan diseases, ophthalmology, CNS diseases and disorders, immunology and autoimmune diseases, and infectious disease), and leading technology platforms (including small molecules, biologics, antibody-based approaches, polymers, gene therapy and other DNA/RNA technologies, preventive and therapeutic vaccines).
We specialize in developing key messages to support each client’s leading position in science innovation and product development. A primary focus is on peer-reviewed validation and collaboration with key opinion leaders (KOLs), presence at medical and industry conferences, and media outreach to support broad visibility of corporate and R&D milestones.
- Corporate Communications, including messaging platform development, crafting of press releases and collateral materials, and website text refinement
- Media Outreach Campaigns
- Medical and Scientific Conference Support
- Strategic Programming to achieve key communications objectives for upcoming milestones, such as financings, M&A and partnering, clinical trial results and peer review publications
- Presentation and Media Coaching